Skip to main content
Signal8

KLAUSNER ARTHUR J

SEC insider (Form 3/4/5 filer). CIK 0001207790. Director at Monopar Therapeutics (MNPR). 5 reported Form 4/5 transactions since Sep 2024; latest on Dec 18, 2025. Located in WILMETTE, IL.

Companies KLAUSNER ARTHUR J has filed insider reports for

  • Monopar Therapeutics (MNPR): Director
KLAUSNER ARTHUR J profile photo

KLAUSNER ARTHUR J

CIK: 0001207790

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (40.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Monopar Therapeutics logo
MNPR

Monopar Therapeutics

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Dec 18, 2025
    Sale
    Direct
    4.7K shares at avg. $67.06$312K
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Dec 18, 2025
    Sale
    Direct
    461 shares at avg. $68.09$31K
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Dec 16, 2025
    Other
    Direct
    7.7K shares-
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Dec 2, 2025
    Award

    Stock Options

    Direct
    2.9K shares-
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Mar 4, 2025
    Award

    Stock Options

    Direct
    11.4K shares-

1-5 of 5